| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.6 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |